Active fragments of angiotensin II: Enzymatic pathways of synthesis and biological effects

被引:80
作者
Ardaillou, R
机构
[1] Hôpital Tenon, 75020 Paris
关键词
D O I
10.1097/00041552-199701000-00006
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Angiotensin (Ang) II is not the only active peptide of the renin-angiotensin system. Several of its degradation products including Ang Ill (obtained by deletion of the N terminal amino acid), Ang IV (obtained by deletion of the two N terminal amino acids) and Ang II(1-7) (obtained by deletion of the C terminal amino acid) also possess biological functions, These peptides are formed via the activity of several enzymes, aminopeptidase A for Ang Ill, aminopeptidases la and N for Ang IV, prolylendopeptidase and carboxypeptidases for Ang II(1-7). Ang Ill possesses most of the properties of Ang II and shares the same receptors. This peptide is particularly important in brain and pituitary physiology and plays a major role in the secretion of arginine vasopressin. Ang IV possesses its own receptors distinct from AT(1) and AT(2). Some of its effects (for example, stimulation of the synthesis of the type 1 inhibitor of plasminogen activator by endothelial cells) were previously attributed to Ang II. Others are opposed to Ang II effects (renal and cerebral vasodilation), Its role in vascular, renal and cerebral physiology remains to be determined. Ang II(1-7) exhibits direct and indirect effects, the latter resulting from Ang II(1-7)-dependent formation of nitric oxide and vasodilatory prostaglandins. Ang II(1-7) recognizes both specific receptors and AT(1) receptors as shown by the partial antagonistic properties of losartan, Ang II(1-7) plays essentially a role in the control of the hydroelectrolytic balance by increasing glomerular filtration rate, urinary output and sodium excretion rate.
引用
收藏
页码:28 / 34
页数:7
相关论文
共 73 条
[11]   Evidence for angiotensin IV receptors in human collecting duct cells [J].
Czekalski, S ;
Chansel, D ;
Vandermeersch, S ;
Ronco, P ;
Ardaillou, R .
KIDNEY INTERNATIONAL, 1996, 50 (04) :1125-1131
[12]   ANGIOTENSIN-IV RECEPTORS AND SIGNALING IN OPOSSUM KIDNEY-CELLS [J].
DULIN, N ;
MADHUN, ZT ;
CHANG, CH ;
BERTIMATTERA, L ;
DICKENS, D ;
DOUGLAS, JG .
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL FLUID AND ELECTROLYTE PHYSIOLOGY, 1995, 269 (05) :F644-F652
[13]   RABBIT RENAL EPITHELIAL ANGIOTENSIN-II RECEPTORS [J].
DULIN, NO ;
ERNSBERGER, P ;
SUCIU, DJ ;
DOUGLAS, JG .
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL FLUID AND ELECTROLYTE PHYSIOLOGY, 1994, 267 (05) :F776-F782
[14]  
ERDOS EG, 1990, KIDNEY INT, V38, pS24
[15]   NEUROPHYSIOLOGICAL RESPONSES TO ANGIOTENSIN-(1-7) [J].
FELIX, D ;
KHOSLA, MC ;
BARNES, KL ;
IMBODEN, H ;
MONTANI, B ;
FERRARIO, CM .
HYPERTENSION, 1991, 17 (06) :1111-1114
[16]   ANGIOTENSIN-(1-7) - A NEW HORMONE OF THE ANGIOTENSIN SYSTEM [J].
FERRARIO, CM ;
BROSNIHAN, KB ;
DIZ, DI ;
JAISWAL, N ;
KHOSLA, MC ;
MILSTED, A ;
TALLANT, EA .
HYPERTENSION, 1991, 18 (05) :S126-S133
[17]   EVIDENCE THAT ANGIOTENSIN-(1-7) PLAYS A ROLE IN THE CENTRAL CONTROL OF BLOOD-PRESSURE AT THE VENTROLATERAL MEDULLA ACTING THROUGH SPECIFIC RECEPTORS [J].
FONTES, MAP ;
SILVA, LCS ;
CAMPAGNOLESANTOS, MJ ;
KHOSLA, MC ;
GUERTZENSTEIN, PG ;
SANTOS, RAS .
BRAIN RESEARCH, 1994, 665 (01) :175-180
[18]   POTENT AND SYSTEMICALLY ACTIVE AMINOPEPTIDASE-N INHIBITORS DESIGNED FROM ACTIVE-SITE INVESTIGATION [J].
FOURNIEZALUSKI, MC ;
CORIC, P ;
TURCAUD, S ;
BRUETSCHY, L ;
LUCAS, E ;
NOBLE, F ;
ROQUES, BP .
JOURNAL OF MEDICINAL CHEMISTRY, 1992, 35 (07) :1259-1266
[19]   POSSIBLE IMPLICATION OF PEPTIDASE ACTIVITY IN DIFFERENT POTENCY OF ANGIOTENSIN-II AND ANGIOTENSIN-III FOR DISPLACING [I-125] ANGIOTENSIN-II BINDING IN PIG AORTA [J].
FUJIMOTO, M ;
MIHARA, S ;
SHIGERI, Y ;
ITAZAKI, K .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1992, 215 (2-3) :259-264
[20]  
GARCIA NH, 1994, J AM SOC NEPHROL, V5, P1133